How much does a bottle of Jisandai (Epclusa) hepatitis C drug cost and the differences among various channels are compared

Epclusa/Epclusa, common name: Sofosbuvir/Velpatasvir) is a broad-spectrum hepatitis C oral antiviral drug that covers almost all genotypes of hepatitis C virus (HCV), so it is widely used in the clinical first-line treatment of hepatitis C. The drug has been officially launched in China and has been included in the medical insurance catalog. For patients who meet the reimbursement conditions, the financial burden is greatly reduced. At present, the price of Jisandai is about more than 3,000 yuan per bottle in regular domestic hospital pharmacies. When purchasing medicine, patients can issue prescriptions through the hospital and enjoy corresponding reimbursement discounts in conjunction with medical insurance policies.

From the perspective of foreign markets, the price of Ji's third-generation original drug has remained high for a long time, especially in Europe and the United States. The cost of each bottle can reach tens of thousands of yuan, which is almost unaffordable for ordinary patients. In order to improve the accessibility of drugs, Gilead has authorized India, Bangladesh and other countries to produce generic drugs of Gilead III. These versions are consistent with the original drugs in terms of drug ingredients, dosage, and efficacy. However, due to low production costs and market pricing, their prices are only a few hundred yuan per bottle, which is far lower than the price of domestic original drugs.

In terms of purchasing channels, if domestic patients want to use medical insurance for reimbursement, the safest and most reliable way is to purchase prescriptions through local regular hospitals and pharmacies. This not only ensures the quality of the drugs, but also enjoys medical insurance discounts. Patients who choose overseas generic drugs mostly obtain them through cross-border drug purchasing channels, including overseas pharmacies, international medical institutions or formal purchasing platforms. It should be noted that although the ingredients of generic drugs are consistent with the original drugs, you must ensure that the channels are regular when purchasing to avoid counterfeit or inferior drugs.

Overall, Jisandai's domestic medical insurance policy has significantly reduced the cost of treatment for patients. The domestic price is more than 3,000 yuan per bottle, which is suitable for patients who pursue formal channels and safety guarantees; while the generic drugs in India and Bangladesh are several hundred yuan per bottle, which has obvious price advantages and is more suitable for patients with greater financial pressure. However, when choosing, you still need to make it under the guidance of a doctor, and give priority to ensuring that the source of the drug is regular and the efficacy is reliable.

Reference materials:https://www.drugs.com/